ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 37 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,503 | -65.1% | 10,586 | -39.8% | 0.00% | – |
| Q1 2023 | $41,503 | -15.9% | 17,586 | -18.7% | 0.00% | – |
| Q4 2022 | $49,332 | -39.8% | 21,637 | -27.2% | 0.00% | – |
| Q3 2022 | $82,000 | +7.9% | 29,737 | -4.5% | 0.00% | – |
| Q2 2022 | $76,000 | -71.9% | 31,137 | -54.5% | 0.00% | -100.0% |
| Q1 2022 | $270,000 | -51.1% | 68,486 | -45.3% | 0.00% | 0.0% |
| Q4 2021 | $552,000 | -22.6% | 125,193 | +8.6% | 0.00% | -50.0% |
| Q3 2021 | $713,000 | +56.7% | 115,324 | +100.5% | 0.00% | +100.0% |
| Q2 2021 | $455,000 | +13.2% | 57,510 | +53.1% | 0.00% | 0.0% |
| Q1 2021 | $402,000 | – | 37,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |